India
· Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
BOM:532321 has a market cap or net worth of INR 994.96 billion. The enterprise value is 994.83 billion.
| Market Cap | 994.96B |
| Enterprise Value | 994.83B |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
| Current Share Class | 1.01B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 248.90M |
Valuation Ratios
The trailing PE ratio is 21.76 and the forward PE ratio is 22.43.
| PE Ratio | 21.76 |
| Forward PE | 22.43 |
| PS Ratio | 4.21 |
| PB Ratio | 3.77 |
| P/TBV Ratio | 6.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 21.76 |
| EV / Sales | 4.21 |
| EV / EBITDA | 14.51 |
| EV / EBIT | 16.77 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | n/a |
| Interest Coverage | 40.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.95% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.46M |
| Profits Per Employee | 1.64M |
| Employee Count | 27,917 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532321 has paid 14.10 billion in taxes.
| Income Tax | 14.10B |
| Effective Tax Rate | 23.03% |
Stock Price Statistics
The stock price has decreased by -15.88% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.88% |
| 50-Day Moving Average | 972.22 |
| 200-Day Moving Average | 943.26 |
| Relative Strength Index (RSI) | 57.97 |
| Average Volume (20 Days) | 46,279 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532321 had revenue of INR 236.08 billion and earned 45.72 billion in profits. Earnings per share was 45.44.
| Revenue | 236.08B |
| Gross Profit | 168.66B |
| Operating Income | 58.60B |
| Pretax Income | 61.21B |
| Net Income | 45.72B |
| EBITDA | 67.68B |
| EBIT | 58.60B |
| Earnings Per Share (EPS) | 45.44 |
Balance Sheet
The company has 56.37 billion in cash and 32.18 billion in debt, giving a net cash position of 24.19 billion.
| Cash & Cash Equivalents | 56.37B |
| Total Debt | 32.18B |
| Net Cash | 24.19B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 263.58B |
| Book Value Per Share | 238.05 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 71.44%, with operating and profit margins of 24.82% and 19.37%.
| Gross Margin | 71.44% |
| Operating Margin | 24.82% |
| Pretax Margin | 25.93% |
| Profit Margin | 19.37% |
| EBITDA Margin | 28.67% |
| EBIT Margin | 24.82% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | 266.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.43% |
| Shareholder Yield | 1.61% |
| Earnings Yield | 4.60% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |